Please login to the form below

Not currently logged in
Email:
Password:

user testing

This page shows the latest user testing news and features for those working in and with pharma, biotech and healthcare.

FDA grants orphan drug status to Allogene’s BCMA-targeted treatment for multiple myeloma

FDA grants orphan drug status to Allogene’s BCMA-targeted treatment for multiple myeloma

ODD designation allows pharma companies to utilise development incentives, such as tax credits for clinical testing, prescription drug user fee exemptions and seven-year marketing exclusivity in the event of regulatory

Latest news

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Patient diversity in clinical trials needs to be centre stage Patient diversity in clinical trials needs to be centre stage

    We took it into a user-testing workshop and every person there said: ‘They don’t represent me, they are not me. ... We design and create in our offices and think we are doing great work but without testing it on a real audience, it is virtually

  • A critical juncture for clinical data management A critical juncture for clinical data management

    Nearly half of respondents cite protocol changes as the top cause for database-build delays; 17% cite user acceptance testing and 15% say it is database design functionality.

  • Achieving insight Achieving insight

    of. It will help you truly empathise with the user and find solutions to those problems you didn’t know existed. ... As a patient engagement business, we are able to combine our expertise in research, human-centred design, user testing and digital

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

Parkinson’s disease: past, present and future
Examining the history and complexities of Parkinson’s disease – one of the most prevalent neurodegenerative disorders that affects over 10 million people worldwide...
The 17th World Congress on Controversies in Neurology
This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...